Tunnel allows real-time global cross-currency payments for free using our Distributed Ledger Technology. We provide our own payment rails, APIs and mobile apps.
Roobrik, Inc. provides online decision tools that help caregivers, senior care providers, and clinicians to make health and care choices. The company was incorporated in 2013 and is based in Greensboro, North Carolina.
MTI, a smart materials and photonics company which is changing the way we use, interact and benefit from light. From healthcare to defense, energy to aerospace– the possibilities are endless
Avhana Health Inc. provides an application to simplify the healthcare provider workflow by offering the latest guidelines, actionable recommendations, and performance metrics—directly in their EHR. Its application features a dashboard for pre-visit planning, patient-specific recommendations for care, corresponding order suggestions that submit to the EHR, and a dashboard for tracking provider activity and performance. The company was founded in 2014 and is based in Baltimore, Maryland.
Validic, Inc. is a healthcare technology company that specializes in a cloud-based platform designed to collect and manage mobile health data from various Internet-enabled applications and devices. Founded in 2010 and headquartered in Durham, North Carolina, Validic provides solutions such as Validic Solution, which connects patient-recorded data from digital health applications and wearables to healthcare providers; Validic Connect, which offers access to less common clinical and consumer devices; and Validic Mobile, focused on data collection from digital health apps and in-home devices. The platform simplifies the management of personal health data, enabling wellness companies, healthcare providers, pharmaceuticals, and health plans to access and utilize this information effectively.
Gemmus Pharma is a drug development company founded in 2007 to commercialize in-licensed technology from a major pharmaceutical company. Gemmus' lead candidate is a cardiovascular drug currently marketed in Asia that has been repurposed for use as a treatment for influenza. Gemmus has received support from the National Institute of Allergy and Infectious Disease (NIAID) and has completed a Series A round. Gemmus plans to file an investigational new drug (IND) application with the FDA for treatment of influenza infections in 2014.
Trusted Metrics Inc., an information security company, offers a cloud-based security incident and event management platform called managed visibility platform with a focus on enabling enterprise visibility and rapid response by consolidating networking, systems, application, and security event information. Its managed visibility platform allows users to track their fixed and dynamic assets, including servers, workstations, and mobile devices; and user identities across multiple devices. The company’s platform also enables users to measure the level of security and protection within their enterprises by providing network monitoring, network, host and wireless intrusion detection, file integrity monitoring, event collaboration, long-term forensic log storage/retrieval, and more; and offers on-demand and scheduled customized alerting and reports. It serves local government, higher education, industrial control systems, insurance and legal, manufacturing, healthcare, and entertainment industries. The company was founded in 2010 and is based in Raleigh, North Carolina. As of July 10, 2018, Trusted Metrics Inc operates as a subsidiary of SolarWinds Worldwide, LLC.
ABK Biomedical Inc. is a Canadian company founded in 2012, based in Halifax, that focuses on the development of embolotherapeutic products aimed at treating uterine fibroids, hypervascular tumors, and arteriovenous malformations. The company integrates clinical market insights with advanced biomaterials to enhance treatment options for patients undergoing embolization, a procedure utilized in interventional radiology. ABK Biomedical is committed to innovating and improving these medical procedures to provide better outcomes for patients suffering from these conditions.
ChaoLogix, Inc. develops computing architecture and chip sets. It offers Chaologix system, a processor and architecture, based on chaotic circuit elements. This system is used in desktop and laptop personal computers, reconfigurable computer video cards for multimedia and gaming, computer network routers, chaotic search engine hardware, power cell phones, and light and adaptable avionics and satellite hardware. Its Chaologix system is also used in specialty computer chips, smart and low power medical devices, robotics, NASA and Department of Defense applications, speedier graphics cards, and self-healing and self-repairing computers. ChaoLogix was founded in 2005 and is based in Gainesville, Florida.
Gemmus Pharma is a drug development company founded in 2007 to commercialize in-licensed technology from a major pharmaceutical company. Gemmus' lead candidate is a cardiovascular drug currently marketed in Asia that has been repurposed for use as a treatment for influenza. Gemmus has received support from the National Institute of Allergy and Infectious Disease (NIAID) and has completed a Series A round. Gemmus plans to file an investigational new drug (IND) application with the FDA for treatment of influenza infections in 2014.
Basho Technologies, Inc. specializes in providing NoSQL database solutions designed for enterprise-scale applications, particularly for Fortune 50 companies. The company’s flagship products include Riak, a distributed NoSQL database that efficiently manages unstructured data across clusters, and Riak CS, a cloud storage solution that supports public, private, and hybrid cloud environments. Basho's offerings also encompass Riak TS for handling time series data, as well as various add-ons like Apache Spark for real-time analytics and Apache Solr for search index synchronization. These tools are aimed at enhancing the performance and scalability of applications in sectors such as gaming, healthcare, retail, telecommunications, and technology. In addition to its software solutions, Basho provides services including implementation, training, and custom analytics. Founded in 2002 and headquartered in Bellevue, Washington, Basho Technologies has evolved from its original name, Basho Strategies Inc., in 2008.
Basho Technologies, Inc. specializes in providing NoSQL database solutions designed for enterprise-scale applications, particularly for Fortune 50 companies. The company’s flagship products include Riak, a distributed NoSQL database that efficiently manages unstructured data across clusters, and Riak CS, a cloud storage solution that supports public, private, and hybrid cloud environments. Basho's offerings also encompass Riak TS for handling time series data, as well as various add-ons like Apache Spark for real-time analytics and Apache Solr for search index synchronization. These tools are aimed at enhancing the performance and scalability of applications in sectors such as gaming, healthcare, retail, telecommunications, and technology. In addition to its software solutions, Basho provides services including implementation, training, and custom analytics. Founded in 2002 and headquartered in Bellevue, Washington, Basho Technologies has evolved from its original name, Basho Strategies Inc., in 2008.
Sensory Analytics, LLC develops advanced sensory solutions for precise measurement in various industrial applications, focusing on color and thickness measurement as well as process control. The company's flagship product line, SpecMetrix, includes automated and portable systems that deliver real-time, non-contact measurement of coating thickness, color, and other quality metrics. These systems provide continuous data with high precision, enabling industries such as aerospace, automotive, coatings, electronics, packaging, medical, and pharmaceuticals to enhance quality assurance and optimize production processes. Founded in 2004 and based in Greensboro, North Carolina, Sensory Analytics aims to improve process control and product quality while reducing operational costs through innovative measurement technologies.
Consolidated Asset Recovery Systems, Inc., based in Raleigh, North Carolina, specializes in software solutions for repossession management and asset recovery. Founded in 2005 by industry veterans, the company has developed the Internet Based Electronic Asset Management (IBEAM) system, which assists banks and dealers in tracking and recovering assets. Its range of services includes repossession management, remarketing, electronic invoice payment, skip tracing, audits, legal demand letter creation, and field assistance. The company operates a vast network of recovery agents across the United States, serving lenders, dealers, and recovery agents. Since its inception, Consolidated Asset Recovery Systems has experienced significant growth and has established itself as a leader in the repossession and remarketing industry, recognized for its compliance and flexibility in adapting to clients' needs. As of 2019, it operates as a subsidiary of Primeritus Financial Services, Inc.
Amulet Pharmaceuticals discovers and develops novel therapeutics using their NORTECHâ„¢ technology to address known liabilities of current therapies serving large unmet markets. Their lead program (AMU-301) treats diabetic gastroparesis an unmet complication of diabetes affecting over 3 million women in the United States.
At Wilmington Pharmaceuticals, they develop and out-license patient-friendly, fast-dissolving formulations for established medicines. They achieve FDA approval and rapid commercialization for their licensing partners, minimizing regulatory risk while maximizing economic opportunity. Their points of differentiation provide you with an ideal development partner.
Affinergy, LLC develops products that purify, concentrate, and remove cells and proteins from tissues and fluids for diagnostic and research applications. It develops a phage display platform that identifies peptides that bind to a variety of targets, such as drugs, proteins, and cells. The company’s products also include implantable devices that deliver and retain biologics at the site of implant in orthopedic procedures and soft tissue repair. The company was founded in 2003 and is based in Durham, North Carolina.